In recognition of Breast Cancer Awareness Month, EMMA International’s whitepaper, Quality and Regulatory Priorities in Breast Cancer Innovation, explores the systems behind reliable diagnostics and treatments. From companion diagnostic development and clinical evidence to manufacturing quality, data integrity, and supply continuity, the paper examines how life sciences organizations can connect their quality and regulatory work to the needs of patients.
Written for pharmaceutical, biotechnology, diagnostic, and medical device organizations, this whitepaper offers practical considerations for strengthening processes throughout development and commercialization. It includes an October action plan and leadership questions to help teams identify gaps, assign responsibility, and evaluate improvements that extend beyond awareness month. Download the whitepaper to explore how your organization can strengthen the systems supporting breast cancer innovation.
Download EMMA International Whitepapers
Complete the form below to receive selected EMMA International whitepapers directly to your inbox.
